Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bermekimab in hidradenitis suppurativa has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Inversa
• Hidradenitis Suppurativa
• Suppurative Hidradenitis

Drugs mentioned

• bermekimab (bermekimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27